Publications

Saha M, Rizzo SA, Ramanathan M, Hightower RM, Santostefano KE, Terada N, Finkel RS, Berg JS, Chahin N, Pacak CA, Wagner RE, Alexander MS, Draper I, Kang PB (2019) Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathy. Hum Mol Genet. 28(14):2365-2377

 

Kuang YL, Munoz A, Nalula G, Santostefano KE, Sanghez V, Sanchez G, Terada N, Mattis AN, Iacovino M, Iribarren C, Krauss RM, Medina MW (2019) Evaluation of commonly used ectoderm markers in iPSC trilineage differentiation. Stem Cell Res 37: 101434

 

Xia G, Terada N, Ashizawa T (2018) Human iPSC Models to Study Orphan Diseases: Muscular Dystrophies. Curr Stem Cell Rep. 4(4):299-309.

 

Wang Y, Hao L, Wang H, Santostefano K, Thapa A, Cleary J, Li H, Guo X, Terada N, Ashizawa T, Xia G (2018) Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9. Mol Ther. 26(11):2617-2630.

 

Jin Y, Liu Y, Li Z, Santostefano K, Shi J, Zhang X, Wu D, Cheng Z, Wu W, Terada N, Jin S, Bai F (2018) Enhanced differentiation of human pluripotent stem cells into cardiomyocytes by bacteria-mediated transcription factors delivery.PLoS One 13(3):e0194895.

 

Taylor JP, Cash MN, Santostefano KE, Nakanishi M, Terada N, Wallet MA (2018) CRISPR/Cas9 knockoutof USP18 enhances type I IFN responsiveness and restricts HIV-1 infection in macrophages. J Leukoc Biol.

 

Wallet MA, Santostefano KE, Terada N, Brusko TM (2017) Isogenic Cellular Systems Model the Impact of Genetic Risk Variants in the Pathogenesis of Type 1 Diabetes. Front Endocrinol 8:276.

 

Watanabe N, Santostefano KE, Yachnis AT, Terada N (2017) A pathologist’s perspective on induced pluripotent stem cells. Lab Invest 97(10):1126-1132.

 

Ferreira RB, Wang M, Law ME, Davis BJ, Bartley AN, Higgins PJ, Kilberg MS, Santostefano KE, Terada N, Heldermon CD, Castellano RK, Law BK (2017) Disulfide bond disrupting agents activate the unfolded protein response in EGFR- and HER2- positive breast tumor cells. Oncotarget 8(17):28971-28989.

 

Hamazaki T, El Rouby N, Fredette NC, Santostefano KE, Terada N (2017) Concise Review: Induced Pluripotent Stem Cell Research in the Era of Precision Medicine. Stem Cells 35(3):545-550.

 

Kilberg MS, Terada N, Shan J (2016) Influence of Amino Acid Metabolism on Embryonic Stem Cell Function and Differentiation. Adv Nutr. 7(4):780S-9S.

 

Gao Y, Guo X, Santostefano K, Wang Y, Reid T, Zeng D, Terada N, Ashizawa T, Xia G (2016) Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy. Mol Ther 24(8):1378-87.

 

Deng C, Li Y, Zhou L, Cho J, Patel B, Terada N, Li Y, Bungert J, Qiu Y, Huang S (2016) HoxBlinc RNA Recruits Set1/MLL Complexes to Activate Hox Gene Expression Patterns and Mesoderm Lineage Development. Cell Rep 14(1):103-114.

 

Biel NM, Santostefano KE, DiVita BB, El Rouby N, Carrasquilla SD, Simmons C, Nakanishi M, Cooper-DeHoff RM, Johnson JA, Terada N (2015) Vascular Smooth Muscle Cells from Hypertensive Patient Derived Induced Pluripotent Stem Cells to Advance Hypertension Pharmacogenomics. Stem Cells Transl Med 4(12): 1380-90.

 

Bai F, Ho Lim C, Jia J, Santostefano K, Simmons C, Kasahara H, Wu W, Terada N, Jin S (2015) Directed Differentiation of Embyonic Stem Cells into Cardiomyocytes by Bacterial Injection of Defined Transcription Factors. Sci Rep 5:15014.

 

Jia J, Bai F, Jin Y, Santostefano KE, Ha UH, Wu D, Wu W, Terada N, Jin S (2015) Efficient Gene Editing in Pluripotent Stem Cells by Bacterial Injection of Transcription Activator-Like Effector Nuclease Proteins. Stem Cells Transl Med 4(8):913-26.

 

Xia G, Gao Y, Jin S, Subramony SH, Terada N, Ranum LPW, Swanson MS, Ashizawa T (2015) Genome modification leads to phenotype reversal in human myotonic dystrophy type 1 induced pluripotent stem cell-derived neural stem cells. Stem Cells, In press [PMID:25702800]

Santostefano KE, Hamazaki T, Biel NM, Jin S, Umezawa A, Terada N (2015) A practical guide to induced pluripotent stem cell research using patient samples. Lab. Invest. 95:4-13

Jia J, Jin Y, Ting B, Wu D, Yang LJ, Terada N, Wu W, Jin S (2014) Bacterial delivery of TALEN proteins for human genome editing. PLoS One 9:e91457

Chen MJ, Lu Y, Hamazaki T, Tsai HY, Erger K, Conlon T, Elshikha AS, Li H, Srivastava A, Yao C, Brantly M, Chiodo V, Hauswirth W, Terada N, Song S (2014) Reprogramming adipose tissue derived mesenchymal stem cells into pluripotent stem cells by a mutant adeno-associated viral vector. Hum. Gene Ther. Methods 25:72-82

Xia G, Santostefano K, Goodwin M, Liu J, Subramony SH, Swanson MS, Terada N and Ashizawa T (2013) Induced pluripotent stem cell as cellular model for myotonic dystrophy type 1. Cell. Reprogram. 15:166-77

Bichsel C, Neeld D, Hamazaki T, Chang LJ, Yang LJ, Terada N and Jin S (2013) Direct reprogramming of fibroblasts to myocytes via bacterial injection of MyoD protein. Cell. Reprogram. 15: 117-25

Xia G, Santostefano K, Hamazaki T, Liu J, Subramony SH, Terada N, and Ashizawa T (2013) Generation of human induced pluripotent stem cells to model spinocerebellar ataxia type 2 in vitro. J. Mol. Neurosci. 51:237-48

Pandian GN, Shinohara K, Ohtsuki A, Nakano Y, Masafumi M, Bando T, Nagase H, Yamada Y, Watanabe A, Terada N, Sato S, Morinaga H, and Sugiyama H (2011) Synthetic small molecules for epigenetic activation of pluripotent genes in mouse embryonic fibroblasts. Chembiochem. 12, 2822-8

Bichsel C, Neeld DK, Hamazaki T, Chang LJ, Yang L, Terada N, and Jin S (2011) Bacterial mediated delivery of nuclear protein into pluripotent and differentiated cells. PLoS One 6, e16465

Hankowski KE, Hamazaki T, Umezawa A, and Terada N (2011) Induced pluripotent stem cell as a next generation biomedical interface. Lab. Invest. 91, 972-7

Gopalakrishnan S, Van Emburgh BO, Shan J, Su Z, Fields CR, Vieweg J, Hamazaki T, Schwartz PH, Terada N, and Robertson KD (2009) A novel DNMT3B splice variant expressed in tumor and pluripotent cells modulates genomic DNA methylation patterns and displays altered DNA binding. Mol. Cancer Res. 7, 1622-34